Work Package Descriptions


WP 1

Development of a governance model for joint influenza vaccine effectiveness studies

To develop a governance model that will allow stakeholders to sustainably fulfil their respective missions and obligations from evidence generated by DRIVE.
WP1 co-leaders: Sanofi Pasteur & FISABIO. Click here to read description of work and role of partners.


WP 2

Development of study tools

To develop tools to support the development of protocols and implementation of DRIVE studies.
WP2 co-leaders: FISABIO & GSK. Click here to read description of work and role of partners.


WP 3

Evaluation of studies’ quality and feasibility

To survey and collect data to support the evaluation of the quality and feasibility of the WP7 pilot studies for determining type/brand-specific seasonal influenza vaccine effectiveness.
Wp3 co-leaders: ISS & Seqirus. Click here to read description of work and role of partners.


WP 4

Framework for analysis and study reports

To create a model to analyse, present, interpret and report influenza VE study results in such a way that all stakeholders can endorse its conclusions.
WP4 co-leaders: Abbott & P95. Click here to read description of work and role of partners.


WP 5

Communication and dissemination of results

To obtain and maintain stakeholder acceptance in DRIVE governance and to effectively communicate the progress of DRIVE to relevant stakeholders.
WP5 co-leaders: THL & Seqirus. Click here to read description of work and role of partners.


WP 6

Project management, coordination and sustainability

To provide overall project leadership and ensure optimal coordination of all project activities, promoting strategic direction, alignment and achievement of the project goals.
WP6 co-leaders: FISABIO & Sanofi Pasteur. Click here to read description of work and role of partners.


WP 7

Influenza Vaccine Effectiveness Pilot Studies

To develop protocols and carry out pilot studies for determining type/brand-specific seasonal influenza vaccine effectiveness in Europe, that meets regulatory requirements.
WP7 co-leaders: ISS & THL. Click here to read description of work and role of partners.


WP 8

Ethics requirements

To develop and ensure compliance with the ‘ethics requirements’ for DRIVE.
WP8 co-leaders: FISABIO & Sanofi Pasteur. Click here to read description of work and role of partners.